Lymphoma - B cell neoplasms
B cell lymphoma subtypes
Age-related EBV-associated B-cell lymphoproliferative disorders
Reviewer: Nikhil Sangle, M.D., University of Utah and ARUP Laboratories (see Reviewers page)
Revised: 23 February 2011, last major update February 2011
Copyright: (c) 2001-2011, PathologyOutlines.com, Inc.
● Clonal proliferation of EBV positive lymphocytes in patients > 50 years, with no known immunodeficiency state or prior lymphoma, and excluding patients with well-defined EBV+ disorders such as primary effusion lymphoma
● Extranodal (skin, lung, tonsil and GI tract) involvement common
● Aggressive disease, with median survival of 2 years (Clin Cancer Res 2007;13:5124)
● Poorer prognosis if age > 70 years or B symptoms
● Effaced lymph node architecture due to large cells (immunoblasts/centroblasts) with admixed reactive small lymphocytes, plasma cells and histiocytes
● Large cells are positive for CD20, CD79a, monoclonal light chain, IRF4/MUM1
● CD10 and bcl6 are often negative
● Clonal population by molecular techniques, in contrast to infectious mononucleosis
End of Lymphoma - B cell neoplasms > B cell lymphoma subtypes > Age-related EBV-associated B-cell lymphoproliferative disorders
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).